As the population of individuals with type 1 diabetes continues to age, a significant new study has revealed that they face nearly three times the risk of developing dementia compared to those without the condition. This alarming finding prompts critical questions about the long-term effects of diabetes on brain health.
In the study, which included 283,772 participants, 5,442 individuals had type 1 diabetes. Among them, 144 developed dementia, representing 2.6% of that group. In contrast, only 0.6% of individuals without diabetes were diagnosed with dementia. After adjusting for factors such as age and education level, researchers found that the overall risk for dementia was about three times higher for those with type 1 diabetes.
Understanding the Increased Risk
The study’s findings align with previous research, including a smaller Swedish study conducted in 2025, which also reported a heightened dementia risk for individuals with type 1 diabetes. This Swedish study had a longer follow-up period of 14 years, compared to the relatively short two-and-a-half-year follow-up in the current study.
One reason for the increased risk is the longer duration of diabetes in type 1 patients, who often develop the condition at a younger age. Chronic disease over many years can elevate the risk for other health issues, including dementia. Additionally, the extreme fluctuations in blood sugar levels associated with type 1 diabetes may contribute to brain health deterioration.
The Blood Sugar Rollercoaster
Type 1 diabetes is characterized by more severe swings in blood sugar levels compared to type 2 diabetes. Frequent episodes of low blood sugar, or hypoglycemia, can harm the brain by stressing nerve cells. Research indicates that individuals with type 1 diabetes experience approximately twice as many low blood sugar episodes as those with type 2 diabetes.
Moreover, the rapid increase in blood sugar following a low episode can further damage brain cells. Recent studies in mice have shown that high blood sugar levels after hypoglycemia can particularly harm the hippocampus, a brain region crucial for learning and memory.
The Insulin Connection
Insulin management is a key factor in the blood sugar variability seen in type 1 diabetes. Unlike type 2 diabetes, which can often be managed with oral medications, type 1 diabetes typically requires multiple daily insulin injections, increasing the risk of hypoglycemia.
Insulin levels are regulated by production and breakdown rates, with the latter involving an enzyme known as insulin-degrading enzyme. This enzyme also breaks down amyloid beta, a protein linked to dementia. When insulin levels are high, the enzyme prioritizes insulin breakdown, allowing amyloid beta to accumulate in the brain.
“Amyloid beta forms sticky plaques in the brain, disrupting cell communication and leading to cell death. These plaques are strongly associated with Alzheimer’s disease, and type 1 diabetes increases the risk of developing Alzheimer’s.”
Additionally, high blood sugar levels can damage blood vessels, increasing the risk of vascular dementia, which is caused by poor blood supply to the brain.
Hope on the Horizon
Despite these concerning links, there is reason for optimism. Advances in diabetes treatment have significantly improved disease management, allowing many individuals with type 1 diabetes to live long, healthy lives. Numerous classes of diabetes medications, including over 50 treatment combinations, are available today.
Some medications, such as metformin, which is primarily used for type 2 diabetes, have shown potential in reducing dementia risk by more than 10%. This drug helps the body use insulin more effectively and is being tested for its benefits in non-diabetic individuals in the Metformin in Alzheimer’s Disease Prevention trial.
Emerging Treatments and Lifestyle Factors
While the effectiveness of weight-loss drugs in reducing dementia risk remains mixed, some studies suggest potential benefits. For instance, the weight-loss drug liraglutide has shown promise in protecting cognition in individuals with mild-to-moderate Alzheimer’s disease.
Physical activity also plays a crucial role in lowering dementia risk. A 2025 study found that engaging in regular exercise, such as 30 minutes per week, could decrease the risk by about 40%. Those who exercised more than 140 minutes per week saw nearly a 70% reduction in risk.
As the understanding of type 1 diabetes and its effects on the brain deepens, staying active and tailoring treatment plans may help mitigate the increased dementia risk. Ongoing research into stem cell therapies for type 1 diabetes offers further hope for future advancements.
This material, originally published by The Conversation, has been edited for clarity, style, and length. Mirage.News does not endorse any institutional positions or take sides, and all views expressed are solely those of the author(s).
